4Filed Aug 12, 8:00 PM ET

Cellebrite (CLBT) Global CRO Jewell Marcus Sells 411 Shares

$CLBT · Cellebrite DI Ltd.

Research Summary

AI-generated summary of this SEC filing

Updated

Cellebrite (CLBT) Global CRO Jewell Marcus Sells 411 Shares

What Happened

  • Jewell Marcus, Global Chief Revenue Officer of Cellebrite DI Ltd. (CLBT), sold 411 shares on 2026-08-12 in an open-market/private sale for a weighted average price of $16.07, generating roughly $6,604 in proceeds. The shares sold were previously granted as RSUs.

Key Details

  • Transaction date: 2026-08-12; weighted average price reported: $16.07.
  • Price range: shares were sold in multiple transactions at prices from $16.0086 to $16.08 (reporting person can provide per-share breakdown on request).
  • Shares disposed: 411; total proceeds ≈ $6,604.
  • Shares owned after the transaction: not specified in the provided filing details.
  • Footnotes: F1 notes the shares were RSUs granted 2025-02-11 and the sale is associated with tax obligations tied to their vesting. F2 explains the weighted-average price and the range of sale prices.
  • Filing status: Report filed 2026-08-13 covering the 2026-08-12 transaction; no indication in the provided details that the filing was late.

Context

  • The filing indicates this was a disposition of previously granted RSUs to satisfy tax obligations, a common administrative sale rather than an explicit signal of confidence or concern. Retail investors should treat small, vesting-related sales differently from voluntary open-market sales by insiders intended as portfolio diversification or market timing.